2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Time-controlled adaptive ventilation (TCAV) accelerates simulated mucus clearance via increased expiratory flow rate

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Ventilator-associated pneumonia (VAP) is the most common nosocomial infection in intensive care units. Distal airway mucus clearance has been shown to reduce VAP incidence. Studies suggest that mucus clearance is enhanced when the rate of expiratory flow is greater than inspiratory flow. The time-controlled adaptive ventilation (TCAV) protocol using the airway pressure release ventilation (APRV) mode has a significantly increased expiratory relative to inspiratory flow rate, as compared with the Acute Respiratory Distress Syndrome Network (ARDSnet) protocol using the conventional ventilation mode of volume assist control (VAC). We hypothesized the TCAV protocol would be superior to the ARDSnet protocol at clearing mucus by a mechanism of net flow in the expiratory direction.

          Methods

          Preserved pig lungs fitted with an endotracheal tube (ETT) were used as a model to study the effect of multiple combinations of peak inspiratory (I PF) and peak expiratory flow rate (E PF) on simulated mucus movement within the ETT. Mechanical ventilation was randomized into 6 groups ( n = 10 runs/group): group 1—TCAV protocol settings with an end-expiratory pressure (P Low) of 0 cmH 2O and P High 25 cmH 2O, group 2—modified TCAV protocol with increased P Low 5 cmH 2O and P High 25 cmH 2O, group 3—modified TCAV with P Low 10 cmH 2O and P High 25 cmH 2O, group 4—ARDSnet protocol using low tidal volume (LTV) and PEEP 0 cmH 2O, group 5—ARDSnet protocol using LTV and PEEP 10 cmH 2O, and group 6—ARDSnet protocol using LTV and PEEP 20 cmH 2O. PEEP of ARDSnet is analogous to P Low of TCAV. Proximal (towards the ventilator) mucus movement distance was recorded after 1 min of ventilation in each group.

          Results

          The TCAV protocol groups 1, 2, and 3 generated significantly greater peak expiratory flow (E PF 51.3 L/min, 46.8 L/min, 36.8 L/min, respectively) as compared to the ARDSnet protocol groups 4, 5, and 6 (32.9 L/min, 23.5 L/min, and 23.2 L/min, respectively) ( p < 0.001). The TCAV groups also demonstrated the greatest proximal mucus movement (7.95 cm/min, 5.8 cm/min, 1.9 cm/min) ( p < 0.01). All ARDSnet protocol groups (4–6) had zero proximal mucus movement (0 cm/min).

          Conclusions

          The TCAV protocol groups promoted the greatest proximal movement of simulated mucus as compared to the ARDSnet protocol groups in this excised lung model. The TCAV protocol settings resulted in the highest E PF and the greatest proximal movement of mucus. Increasing P Low reduced proximal mucus movement. We speculate that proximal mucus movement is driven by E PF when E PF is greater than I PF, creating a net force in the proximal direction.

          Related collections

          Most cited references14

          • Record: found
          • Abstract: found
          • Article: not found

          Other approaches to open-lung ventilation: airway pressure release ventilation.

          To review the use of airway pressure release ventilation (APRV) in the treatment of acute lung injury/acute respiratory distress syndrome. Published animal studies, human studies, and review articles of APRV. APRV has been successfully used in neonatal, pediatric, and adult forms of respiratory failure. Experimental and clinical use of APRV has been shown to facilitate spontaneous breathing and is associated with decreased peak airway pressures and improved oxygenation/ventilation when compared with conventional ventilation. Additionally, improvements in hemodynamic parameters, splanchnic perfusion, and reduced sedation/neuromuscular blocker requirements have been reported. APRV may offer potential clinical advantages for ventilator management of acute lung injury/acute respiratory distress syndrome and may be considered as an alternative "open lung approach" to mechanical ventilation. Whether APRV reduces mortality or increases ventilator-free days compared with a conventional volume-cycled "lung protective" strategy will require future randomized, controlled trials.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            The 30-year evolution of airway pressure release ventilation (APRV)

            Airway pressure release ventilation (APRV) was first described in 1987 and defined as continuous positive airway pressure (CPAP) with a brief release while allowing the patient to spontaneously breathe throughout the respiratory cycle. The current understanding of the optimal strategy to minimize ventilator-induced lung injury is to “open the lung and keep it open”. APRV should be ideal for this strategy with the prolonged CPAP duration recruiting the lung and the minimal release duration preventing lung collapse. However, APRV is inconsistently defined with significant variation in the settings used in experimental studies and in clinical practice. The goal of this review was to analyze the published literature and determine APRV efficacy as a lung-protective strategy. We reviewed all original articles in which the authors stated that APRV was used. The primary analysis was to correlate APRV settings with physiologic and clinical outcomes. Results showed that there was tremendous variation in settings that were all defined as APRV, particularly CPAP and release phase duration and the parameters used to guide these settings. Thus, it was impossible to assess efficacy of a single strategy since almost none of the APRV settings were identical. Therefore, we divided all APRV studies divided into two basic categories: (1) fixed-setting APRV (F-APRV) in which the release phase is set and left constant; and (2) personalized-APRV (P-APRV) in which the release phase is set based on changes in lung mechanics using the slope of the expiratory flow curve. Results showed that in no study was there a statistically significant worse outcome with APRV, regardless of the settings (F-ARPV or P-APRV). Multiple studies demonstrated that P-APRV stabilizes alveoli and reduces the incidence of acute respiratory distress syndrome (ARDS) in clinically relevant animal models and in trauma patients. In conclusion, over the 30 years since the mode’s inception there have been no strict criteria in defining a mechanical breath as being APRV. P-APRV has shown great promise as a highly lung-protective ventilation strategy.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Early application of airway pressure release ventilation may reduce mortality in high-risk trauma patients: a systematic review of observational trauma ARDS literature.

              Adult respiratory distress syndrome is often refractory to treatment and develops after entering the health care system. This suggests an opportunity to prevent this syndrome before it develops. The objective of this study was to demonstrate that early application of airway pressure release ventilation in high-risk trauma patients reduces hospital mortality as compared with similarly injured patients on conventional ventilation.
                Bookmark

                Author and article information

                Contributors
                melissa.mahajan@gmail.com
                distefad@upstate.edu
                315-464-1696 , satalinj@upstate.edu
                pandrews@umm.edu
                hassalkhalisy@gmail.com
                blairs@upstate.edu
                Louis.gatto@cortland.edu
                niemang@upstate.edu
                nhabashi@som.umaryland.edu
                Journal
                Intensive Care Med Exp
                Intensive Care Med Exp
                Intensive Care Medicine Experimental
                Springer International Publishing (Cham )
                2197-425X
                16 May 2019
                16 May 2019
                December 2019
                : 7
                : 27
                Affiliations
                [1 ]ISNI 0000 0000 9159 4457, GRID grid.411023.5, Department of Surgery, , SUNY Upstate Medical University, ; 750 East Adams St., 766 Irving Avenue, Syracuse, NY 13210 USA
                [2 ]ISNI 0000 0001 2175 4264, GRID grid.411024.2, Department of Trauma Critical Care Medicine, R Adams Cowley Shock Trauma Center, , University of Maryland School of Medicine, ; 22 S. Greene Street, Baltimore, MD 21201 USA
                [3 ]ISNI 0000 0000 9340 0716, GRID grid.264266.2, Department of Biological Sciences, , SUNY Cortland, ; 22 Graham Avenue, Cortland, NY 13045 USA
                Author information
                http://orcid.org/0000-0002-7582-2493
                Article
                250
                10.1186/s40635-019-0250-5
                6522588
                31098761
                9aa4544e-7ddb-498e-a125-4fd039281e1d
                © The Author(s). 2019

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

                History
                : 22 January 2019
                : 29 April 2019
                Categories
                Research
                Custom metadata
                © The Author(s) 2019

                airway pressure release ventilation (aprv) mode,expiratory flow rate,mucus,time-controlled adaptive ventilation (tcav),ventilator-associated pneumonia (vap),ardsnet ventilation,volume assist control (vac) mode,mucus removal

                Comments

                Comment on this article